Fig. 4. Clinical presentation and age of onset in MOGAD and SP-NMOSD. (A) The onset of MOGAD tended to occur at a younger age than that of seropositive NMOSD (34.2±16.6 yrs vs. 39.6±15.7 yrs, P=0.105). (B) The proportions of clinical syndromes at onset differed between patients with MOGAD and patients with SP-NMOSD (P=0.007).
Abbreviations: TM, transverse myelitis; ON, optic neuritis; MOGAD, myelin oligodendrocyte glycoprotein autoantibody-associated disease; SP-NMOSD, seropositive neuromyelitis optica spectrum disorder.

Ann Lab Med 2024;44:56~63 https://doi.org/10.3343/alm.2024.44.1.56